Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Affluent Medical SA ( (FR:AFME) ) just unveiled an update.
Affluent Medical announced the total number of shares and voting rights as of December 31, 2024, which plays a crucial role in the company’s governance and shareholder decision-making. This transparency aligns with regulations and supports the company’s strategic plans, potentially impacting its market presence and stakeholder relations.
More about Affluent Medical SA
Affluent Medical is a French medical technology company founded by Truffle Capital. It focuses on developing next-generation implants for treating structural heart diseases and urinary incontinence, aiming to restore essential physiological functions with minimally invasive, innovative, adjustable, and biomimetic solutions. The company aims to market its products by 2026, following successful clinical studies and securing necessary funding.
YTD Price Performance: 9.92%
Average Trading Volume: 2,500
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €58.2M
For detailed information about AFME stock, go to TipRanks’ Stock Analysis page.
